StockTipsArenaBeta

BUY Mankind Pharma Limited — Ashish Kyal, Waves Strategy Advisors

BUYMankind Pharma Limited
Mankind Pharma share price target & all analyst calls

byAshish Kyal, Waves Strategy AdvisorsHorizon: NA (inferred Swing (≤2wk))24 Sept 2026via ET Now (Live)

Entry₹2,481Inferred
Target₹2,640
Total upside +6.41% (call closed)
Stop loss₹2,425-2.26% risk
Exit₹2,4258 Oct 2026, 11:00 am
Stop-loss hit-2.26%
Follow Ashish Kyal for new calls(30% target hit, 182 closed calls)Get alertsWatch MANKIND for new buy/sell callsGet alertsSee 2 active Swing calls on MANKINDSee 282 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 8 Oct 2026
3 supporting3 neutral2 opposing
Supports the BUY call (3)

3 advisors have active short-term BUY calls on this stock, all issued in the last 14 days

Advisor consensus · adjacent horizon·30 Sept · 1w ago

Mankind Pharma shares up 10% in just 4 sessions; Kotak upgrades the stock - Target, share price trend

NewsLivemint·22 Sept · 2w ago

(opens in new tab)

Mankind Pharma shares get an upgrade from Kotak; Price target among top five on the street

NewsCnbc-Tv18·22 Sept · 2w ago

(opens in new tab)
Neutral / worth noting (3)

Mankind Pharma To Give Rs 1 Crore To Flydubai Captain Smit Machchhar, Family For Averting Flight Disaster

NewsNdtv-Profit·3 Oct · 4d ago

(opens in new tab)

Mankind Pharma Gets 68.21 ESG Rating From Niche99 In Leader Category

NewsGoogle News·15 Sept · 3w ago

(opens in new tab)

Mankind Pharma to attend three investor conferences in September 2026

NewsGoogle News·11 Sept · 4w ago

(opens in new tab)
Weighs against the BUY call (2)

Mankind Pharma auditor resigns as subsidiary Bharat Serums enters liquidation

NewsGoogle News·28 Sept · 1w ago

(opens in new tab)

Mankind Pharma's subsidiary Bharat Serums and Vaccines sees auditor resignation amid liquidation

NewsGoogle News·28 Sept · 1w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Mankind Pharma

All analyst calls on Mankind Pharma

More from Ashish Kyal, Waves Strategy Advisors

Every call and its outcome